Groove Botanicals, Inc (GRVE) Fair Value & Analysis
Energy · US · Market cap $245K
Groove Botanicals, Inc
GRVE · US
Fair value as of: Aug 18, 2026
From 2 valuation models · updated today
Share price +2.5% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- The models converge in a tight band ($0.0040 to $0.0042), unusually little disagreement for a valuation.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 18, 2026.
How to read this chart
60‑month range $0.0012 – $0.2900 · fair‑value band $0.0040 – $0.0042 · the $0.0041 price screens below the $0.0041 fair value. Dashed = 300-day average. As of Aug 18, 2026.
Analysis
Groove Botanicals, Inc (GRVE) currently trades at $0.0041, while our model-based Fair Value estimate is $0.0041, implying the stock looks roughly 0.0% fairly valued today. The Quality Score stands at 51/100 (solid quality), in the Energy sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Trailing-twelve-month revenue stands at $8.1K. Revenue grew 46.1% year over year. Fundamentals as of Aug 18, 2026
Our scenario range runs from $0.0040 (bear case) to $0.0042 (bull case); at $0.0041, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Energy peers we cover trades at -35% fair-value upside, at 0%, GRVE screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 2 models by family
Notify me when GRVE reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 18, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 50 · Market factors (momentum, volatility) 17
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Groove Botanicals, Inc., focuses on identifying and evaluating potential licensing, development, or commercialization opportunities involving early-stage technologies and applied intellectual property that originate from universities and research institutions in Norway. The company was formerly known as Avalon Oil & Gas, Inc.
Full company description
Groove Botanicals, Inc., focuses on identifying and evaluating potential licensing, development, or commercialization opportunities involving early-stage technologies and applied intellectual property that originate from universities and research institutions in Norway. The company was formerly known as Avalon Oil & Gas, Inc. and changed its name to Groove Botanicals, Inc. in May 2018. Groove Botanicals, Inc. is headquartered in Minneapolis, Minnesota.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Groove Botanicals, Inc reported revenue of $0 in FY2026 versus $8.1K in FY2022. Reported net income was −$140K in FY2026.
Watch GRVE: get an alert when its fair value changes →
Peer Group
Oil & Gas E&P · 318 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Oil & Gas E&P median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Oil & Gas E&P stocks, each showing price versus our Fair Value estimate (as of Aug 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| CNOOC Limited 600938 | ¥32.85 | ¥32.55 | -1% |
| ConocoPhillips explores for, COP | $126.78 | $90.15 | -29% |
| Canadian Natural Resources Limited CNQ | $47.57 | $31.14 | -35% |
| EOG Resources, Inc EOG | $143.14 | $130.19 | -9% |
| Occidental Petroleum Corporation OXY | $58.55 | $30.06 | -49% |
| Diamondback Energy, Inc FANG | $201.71 | $105.24 | -48% |
| Devon Energy Corporation DVN | $44.86 | $27.06 | -40% |
| Woodside Energy Group WDS | A$32.55 | A$20.71 | -36% |
| EQT Corporation EQT | $54.06 | $42.85 | -21% |
| Texas Pacific Land Corporation TPL | $342.77 | $77.26 | -77% |
Compare Groove Botanicals, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Energy stocks →
Frequently asked questions
Is Groove Botanicals, Inc (GRVE) overvalued or undervalued?
What is the fair value of GRVE?
What is the quality score of GRVE?
What is the revenue of Groove Botanicals, Inc (GRVE)?
What is the net profit margin of GRVE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Groove Botanicals, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.